Tucatinib in patients with HER2-positive advanced/metastatic breast cancer: A systematic literature review of real-world evidence.
- DOI
- 10.1016/j.breast.2026.104837
- Published
- 2026 Aug
- Container
- Breast (Edinburgh, Scotland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.breast.2026.104837,
title = {Tucatinib in patients with HER2-positive advanced/metastatic breast cancer: A systematic literature review of real-world evidence.},
author = {Sanchez-Bayona R and Anders C and Bartsch R and Cameron DA and Ciruelos EM and Criscitiello C and Duhoux FP and Foukakis T and Frenel JS and Gligorov J and Kaufman PA and Lambertini M and LeVasseur N and Okines A and Penault-Llorca F and Müller V and Blahna MT and Neuberger E and Simon S and Zanucco E and Rosé C and Curigliano G and Harbeck N},
year = {2026},
journal = {Breast (Edinburgh, Scotland)},
doi = {10.1016/j.breast.2026.104837},
url = {https://doi.org/10.1016/j.breast.2026.104837}
}RIS
TY - JOUR TI - Tucatinib in patients with HER2-positive advanced/metastatic breast cancer: A systematic literature review of real-world evidence. AU - Sanchez-Bayona R AU - Anders C AU - Bartsch R AU - Cameron DA AU - Ciruelos EM AU - Criscitiello C AU - Duhoux FP AU - Foukakis T AU - Frenel JS AU - Gligorov J AU - Kaufman PA AU - Lambertini M AU - LeVasseur N AU - Okines A AU - Penault-Llorca F AU - Müller V AU - Blahna MT AU - Neuberger E AU - Simon S AU - Zanucco E AU - Rosé C AU - Curigliano G AU - Harbeck N PY - 2026 JO - Breast (Edinburgh, Scotland) DO - 10.1016/j.breast.2026.104837 UR - https://doi.org/10.1016/j.breast.2026.104837 ER -
APA
R, S., C, A., R, B., DA, C., EM, C., C, C., FP, D., T, F., JS, F., J, G., PA, K., M, L., N, L., A, O., F, P., V, M., MT, B., E, N., S, S., E, Z., C, R., G, C., & N, H. (2026). Tucatinib in patients with HER2-positive advanced/metastatic breast cancer: A systematic literature review of real-world evidence.. Breast (Edinburgh, Scotland). https://doi.org/10.1016/j.breast.2026.104837
Source records
- pubmed · retrieved 2026-09-26T12:05:07.472Z